Wago Corporation: Ethernet adapters provide tool-free terminations

WAGO’s 756 Series M12 Socket Ethernet Adapter simplifies the integration of machine-mount IP67 components with IP20 controls.

Pw 41454 Image 25

Providing tool-free terminations, the D-Coded M12 Adapter features a traditional cable-based RJ45 Ethernet socket that routes data through a screw-locking M12 connector. A panel-mount design and availability in right-angle (756-9503) and straight (756-9504) variants eases integration into existing systems. 

The adapters provide Class D (up to 100 MHz) transmission performance. To support data transmission to/from components in harsh environments, the adapters are 360° shielded to Category 5 standards. Network-based configuration replaces proprietary handheld configuration units and required training to streamline machine-building and control applications for industries such as packaging, food/beverage and pharmaceutical.

750-675 also economizes device maintenance, minimizing service for difficult-to-access applications.  The I/O-Link Module bolsters application reliability via vibration-proof and maintenance-free CAGE CLAMP Spring Pressure Connection Technology. Approvals: CE Conformity, UL/cUL (UL 508) and Electromagnetic Immunity (EN 61000-6-2).

 

Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Annual Outlook Report: Workforce
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report